Bristol-Myers Squibb Wins U.S. Approval for Ipilimumab to Treat Melanoma – Good News for Men with Advanced Prostate Cancer
Bristol-Myers Squibb Co. announced today (March 25) that it has received FDA approval for ipilimumab, the first drug in a new family of medicines to treat advanced melanoma, the most deadly form of skin cancer. This is potentially good news for those of us who are fighting advanced prostate cancer as there is currently an [...]
